H. Imai et al., NOVEL NUCLEAR AUTOANTIGEN WITH SPLICING FACTOR MOTIFS IDENTIFIED WITHANTIBODY FROM HEPATOCELLULAR-CARCINOMA, The Journal of clinical investigation, 92(5), 1993, pp. 2419-2426
A patient with liver cirrhosis who progressed to hepatocellular carcin
oma was found to develop novel antinuclear antibodies. The serum was u
sed to isolate full-length cDNA clones encoding related proteins of 53
0 amino acids (representative clone HCC1.4) and 524 amino acids (repre
sentative clone HCC1.3). Affinity-purified antibodies eluted from reco
mbinant proteins recognized a 64-kD nuclear protein in Western blottin
g and decorated the nucleoplasm in a speckled-network fashion in immun
ofluorescence, colocalizing with antibodies to pre-mRNA splicing facto
r SC35 and uridine-rich small nuclear RNAs. The deduced amino acid seq
uence contained an arginine/serine-rich (RS) domain and three-ribonucl
eoprotein consensus sequence domains, two classes of motifs present in
several splicing factors. A repeating octapeptide of Arg-Ser-Arg-Ser-
Arg(Lys)-Glu(Asp)-Arg-Lys(Arg) was present in RS region of HCC1. This
octapeptide sequence called RS-ERK motif was also found in splicing fa
ctors U2AF 35- and 65-kD proteins and 70-kD U1 small nuclear ribonucle
oprotein. The molecular features and immunolocalization data suggest t
hat the HCC1 autoantigen may be associated with splicing activities an
d are consistent with observations that autoantibody responses frequen
tly target molecules involved in important cellular biosynthetic funct
ions.